معرفی
Dr. Jessamy Tiffen is an Adjunct Senior Lecturer at the University of Sydney's School of Medical Sciences and Head of the Melanoma Epigenetics Laboratory at the Centenary Institute. She holds an Honorary Senior Research Fellowship at the Faculty of Medicine and Health. Her research focuses on epigenetic modifiers in melanoma, particularly mechanisms driving resistance to treatment, sex-based survival disparities, and immune response modulation.
Her current projects include investigating X-linked epigenetic regulators' role in male melanoma mortality, identifying epigenetic drivers of drug resistance, enhancing immunotherapy efficacy via epigenetic targeting, and understanding melanoma dedifferentiation. She has secured grants from organizations like Cancer Council NSW and Therapeutic Innovations Australia.
Key awards include the 2021 Cancer Institute NSW Career Development Fellowship and the 2020 The Educator Rising Star Award. Her work spans over 30 peer-reviewed publications, with recent contributions exploring BET protein inhibition and X chromosome-linked survival advantages.
Dr. Tiffen advises students in Honours, Masters, and PhD programs, focusing on translational research with clinical impact. She leads a multidisciplinary team at the Centenary Institute's Melanoma Immunology and Oncology Program, emphasizing gender equity and graduate mentoring.
